Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity

Detalhes bibliográficos
Autor(a) principal: Freitas, AT
Data de Publicação: 2021
Outros Autores: Calhau, C, Antunes, G, Araújo, B, Bandeira, M, Barreira, S, Bazenga, F, Braz, S, Caldeira, D, Santos, SCR, Faria, A, Faria, D, Fraga, M, Nogueira-Garcia, B, Gonçalves, L, Kovalchuk, P, Lacerda L, Lopes, H, Luís, D, Medeiros, F, Melo, AMP, Melo-Cristino, J, Miranda, A, Pereira, C, Pinto, AT, Pinto, J, Proença, H, Ramos, A, Rato, JPR, Rocha, F, Rocha, JC, Moreira-Rosário, A, Vazão, H, Volovetska, Y, Guimarães, JT, Pinto, FJ
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/149595
Resumo: Vitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases.
id RCAP_30bd156083407f72f98c10a954003f7e
oai_identifier_str oai:repositorio-aberto.up.pt:10216/149595
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severityImmunogeneticsPredictive markersRisk factorsViral infectionVitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases.Nature Research20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/149595eng2045-232210.1038/s41598-021-99952-zFreitas, ATCalhau, CAntunes, GAraújo, BBandeira, MBarreira, SBazenga, FBraz, SCaldeira, DSantos, SCRFaria, AFaria, DFraga, MNogueira-Garcia, BGonçalves, LKovalchuk, PLacerda LLopes, HLuís, DMedeiros, FMelo, AMPMelo-Cristino, JMiranda, APereira, CPinto, ATPinto, JProença, HRamos, ARato, JPRRocha, FRocha, JCMoreira-Rosário, AVazão, HVolovetska, YGuimarães, JTPinto, FJinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T13:47:05Zoai:repositorio-aberto.up.pt:10216/149595Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:47:30.780487Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
title Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
spellingShingle Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
Freitas, AT
Immunogenetics
Predictive markers
Risk factors
Viral infection
title_short Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
title_full Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
title_fullStr Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
title_full_unstemmed Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
title_sort Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
author Freitas, AT
author_facet Freitas, AT
Calhau, C
Antunes, G
Araújo, B
Bandeira, M
Barreira, S
Bazenga, F
Braz, S
Caldeira, D
Santos, SCR
Faria, A
Faria, D
Fraga, M
Nogueira-Garcia, B
Gonçalves, L
Kovalchuk, P
Lacerda L
Lopes, H
Luís, D
Medeiros, F
Melo, AMP
Melo-Cristino, J
Miranda, A
Pereira, C
Pinto, AT
Pinto, J
Proença, H
Ramos, A
Rato, JPR
Rocha, F
Rocha, JC
Moreira-Rosário, A
Vazão, H
Volovetska, Y
Guimarães, JT
Pinto, FJ
author_role author
author2 Calhau, C
Antunes, G
Araújo, B
Bandeira, M
Barreira, S
Bazenga, F
Braz, S
Caldeira, D
Santos, SCR
Faria, A
Faria, D
Fraga, M
Nogueira-Garcia, B
Gonçalves, L
Kovalchuk, P
Lacerda L
Lopes, H
Luís, D
Medeiros, F
Melo, AMP
Melo-Cristino, J
Miranda, A
Pereira, C
Pinto, AT
Pinto, J
Proença, H
Ramos, A
Rato, JPR
Rocha, F
Rocha, JC
Moreira-Rosário, A
Vazão, H
Volovetska, Y
Guimarães, JT
Pinto, FJ
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Freitas, AT
Calhau, C
Antunes, G
Araújo, B
Bandeira, M
Barreira, S
Bazenga, F
Braz, S
Caldeira, D
Santos, SCR
Faria, A
Faria, D
Fraga, M
Nogueira-Garcia, B
Gonçalves, L
Kovalchuk, P
Lacerda L
Lopes, H
Luís, D
Medeiros, F
Melo, AMP
Melo-Cristino, J
Miranda, A
Pereira, C
Pinto, AT
Pinto, J
Proença, H
Ramos, A
Rato, JPR
Rocha, F
Rocha, JC
Moreira-Rosário, A
Vazão, H
Volovetska, Y
Guimarães, JT
Pinto, FJ
dc.subject.por.fl_str_mv Immunogenetics
Predictive markers
Risk factors
Viral infection
topic Immunogenetics
Predictive markers
Risk factors
Viral infection
description Vitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases.
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/149595
url https://hdl.handle.net/10216/149595
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2045-2322
10.1038/s41598-021-99952-z
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Nature Research
publisher.none.fl_str_mv Nature Research
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135792987111424